S 538 requires applicants seeking to locate a substance use disorder treatment center within 500 feet of a school to notify local municipal and county planning officials before submitting their main license application. It mandates that applicants also request a resolution of local support from the municipal governing body and submit this resolution along with their license application. This bill directly affects treatment center applicants who wish to operate near schools, adding a community engagement step to the approval process. The requirement applies to new applications submitted after the bill's effective date, modifying existing licensing procedures under New Jersey law. The bill does not change the definition of treatment centers or apply to existing applications filed before enactment.
This bill shifts $45 million in state funding for opioid care from the Opioid Recovery and Remediation Fund to the General Fund for the 2026 fiscal year. The funds must be distributed to four specific hospitals - $10 million to Hackensack, $15 million to RWJ Barnabas, $15 million to Cooper, and $5 million to Atlantic Health - to provide opioid-related treatment. Each hospital must submit quarterly reports detailing fund usage, patient outcomes, and remaining balances until all funds are expended.
S 2581 establishes a tax credit program in New Jersey to incentivize employers to hire and retain individuals in recovery from substance use disorder. Employers must become "certified" by partnering with treatment providers, offering qualifying health insurance, and meeting other criteria to qualify for the program. Certified employers can claim a tax credit of $1 per hour worked by eligible employees, up to $2,000 per employee annually, for part-time or full-time employment. The program, administered by the Division of Mental Health and Addiction Services, allocates up to $2 million yearly and requires employers to verify employee eligibility and recovery status. This bill directly affects New Jersey employers seeking tax incentives and individuals with substance use disorder seeking stable employment.
This bill establishes a three-year pilot program for school-based mentoring in New Jersey public schools located within 1,000 feet of where gunfire occurred in the prior school year (a "crisis zone"). It directly affects kindergarten through third-grade students at risk for mental health issues or substance abuse, targeting improvements in their emotional resilience, social skills, and behavior. The program requires participating schools to use a weekly, 25-minute one-on-one mentoring curriculum focused on monitoring emotions, building coping skills, and maintaining emotional control, with schools selecting mentors and evaluating student progress at three intervals. After the pilot, the Commissioner of Education must report on whether the program could be expanded statewide.
This bill requires New Jersey's Medicaid program to cover substance use disorder treatment services provided by community-based organizations (CBOs), directly expanding access for Medicaid recipients. It establishes new standards for opioid treatment programs, including allowing "medication units" (geographically separate clinics or mobile units) to administer medication-assisted treatment like methadone or buprenorphine. The bill also prohibits treatment programs from denying care based on a patient's refusal of counseling or missing doses, and sets limits on mandatory drug screenings. These changes aim to make treatment more accessible while maintaining clinical standards for opioid use disorder care.
This bill (S 455) is mislabeled in its title; the actual text amends **special probation rules for substance use disorder cases**, not expungement statutes. It creates a new "special probation" option for individuals with substance use disorders convicted of certain offenses (excluding serious violent crimes), requiring a court to assess their condition, confirm the offense was drug/alcohol-related, and ensure no prior violent convictions. If approved, offenders must enter licensed residential or nonresidential treatment (including medication-assisted therapy) with regular drug testing, replacing incarceration. The bill directly affects people with substance use disorders who meet strict eligibility criteria, aiming to reduce prison time by prioritizing treatment over punishment. *(Note: The bill's title incorrectly references "expungement" despite the text focusing solely on probation and treatment programs.)*
This bill (S 2887) expands eligibility for New Jersey inmates to participate in residential community release programs (RCRPs). It allows inmates scheduled for release in less than 30 months (previously 18-24 months) to join RCRPs if the Department of Corrections (DOC) deems it appropriate, or inmates with 12-30 months remaining who need substance use disorder treatment. The bill also requires the DOC to report monthly to the Legislature (not just the budget office) on RCRP bed capacity for inmates 30-36 months from release. Additionally, it prohibits returning inmates to correctional facilities solely for medical conditions or pregnancy, and bans punitive measures for medical needs during RCRP participation.
S 2886 revises New Jersey's Work First New Jersey program to allow individuals convicted of drug-related offenses (involving possession, use, or distribution of controlled substances) to qualify for general assistance benefits if they enroll in or complete a licensed drug treatment program. Previously ineligible individuals can now access benefits through treatment participation, with exceptions if no program is available or for approved "good cause" excuses. Benefits are paid directly to the treatment provider during participation and to the individual after completion, requiring drug testing for 60 days post-treatment (except for prescribed medications). This change applies to those convicted on or after August 22, 1996, under state or federal law.
This bill requires New Jersey high school districts (grades 9-12) to add mandatory instruction about compulsive gambling risks to their health and physical education curriculum. The content must cover gambling addiction dangers, financial risks, and probability concepts. The state education commissioner must provide student resources and develop teacher training on identifying gambling issues and treatment options. Implementation begins in the school year after the commissioner completes the training module and updates the state education standards.
This bill (S 1399, "Clinical Laboratory Services Reimbursement and Vulnerable Patient Discount Act") permits clinical laboratories to offer discounts to patients facing financial hardship without reducing NJ FamilyCare reimbursement rates or violating anti-rebate rules. It directly affects labs serving vulnerable populations - including uninsured, homeless, or low-income patients seeking services like drug testing for substance use disorder treatment - by allowing them to discount charges based on documented financial hardship (e.g., income below 200% of federal poverty level). Key provisions require labs to maintain NJ FamilyCare reimbursement rates at the lower of the fee schedule or their standard public charge, while discounts to vulnerable patients must align with federal anti-rebate rules. The bill aims to prevent labs from ceasing discounted services due to prior enforcement risks under NJ FamilyCare regulations.